Correlation Between Spyre Therapeutics and Delta Air

Can any of the company-specific risk be diversified away by investing in both Spyre Therapeutics and Delta Air at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spyre Therapeutics and Delta Air into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Spyre Therapeutics and Delta Air Lines, you can compare the effects of market volatilities on Spyre Therapeutics and Delta Air and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spyre Therapeutics with a short position of Delta Air. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spyre Therapeutics and Delta Air.

Diversification Opportunities for Spyre Therapeutics and Delta Air

-0.08

Correlation Coefficient

Spyre Therapeutics  Delta Air

Good diversification

The 3 months correlation between Spyre and Delta is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding Spyre Therapeutics and Delta Air Lines in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Delta Air Lines and Spyre Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spyre Therapeutics are associated (or correlated) with Delta Air. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Delta Air Lines has no effect on the direction of Spyre Therapeutics i.e., Spyre Therapeutics and Delta Air go up and down completely randomly.

Pair Corralation between Spyre Therapeutics and Delta Air

Given the investment horizon of 90 days Spyre Therapeutics is expected to under-perform the Delta Air. In addition to that, Spyre Therapeutics is 2.21 times more volatile than Delta Air Lines. It trades about -0.19 of its total potential returns per unit of risk. Delta Air Lines is currently generating about -0.06 per unit of volatility. If you would invest  6,414  in Delta Air Lines on September 27, 2024 and sell it today you would lose (158.00) from holding Delta Air Lines or give up 2.46% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Spyre Therapeutics  vs.  Delta Air Lines

Spyre Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Spyre Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Delta Air Lines

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Delta Air Lines are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite quite conflicting basic indicators, Delta Air disclosed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Spyre Therapeutics and Delta Air

The main advantage of trading using opposite Spyre Therapeutics and Delta Air positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spyre Therapeutics position performs unexpectedly, Delta Air can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Delta Air will offset losses from the drop in Delta Air's long position.

The idea behind Spyre Therapeutics and Delta Air Lines pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.